Midgard Science
TO

TD2 Oncology

Scottsdale, AZ, United States td2inc.com

From their website, Nov 2026

Work here? Claim this listing

About

TD2 Oncology is an oncology contract research organization that supports drug development from preclinical work through clinical trial management and regulatory support. It serves biotech and pharmaceutical sponsors developing oncology therapies, including radiopharmaceuticals, hematologic malignancies, antibody-drug conjugates, small molecules, and cancer vaccines. The company is based in Scottsdale, Arizona.

Services

  • Clinical trial services

    Provides Phase I, II, and III clinical trial design, planning, execution, data analysis, and final reporting for oncology studies.

    Assays & in vitro testing

  • Study design & protocol development

    Develops oncology trial protocols and study designs tailored to the therapy and indication.

    Assays & in vitro testing

  • Patient identification and site engagement

    Identifies patients and engages study sites for oncology clinical trials.

    Assays & in vitro testing

  • Site management and monitoring

    Manages and monitors clinical sites during oncology trials.

    Assays & in vitro testing

  • Strategic third-party vendor management

    Coordinates third-party vendors supporting clinical trial operations.

    Assays & in vitro testing

  • Biostatistics

    Provides statistical support for clinical trial design and analysis.

    Assays & in vitro testing

  • Data management

    Manages clinical trial data collection, organization, and analysis.

    Assays & in vitro testing

  • Clinical flow cytometry

    Performs flow cytometry services for oncology clinical trials and translational work.

    Assays & in vitro testing

  • Pharmacovigilance

    Supports safety monitoring and adverse event oversight for clinical trials.

    Assays & in vitro testing

  • Medical monitoring services

    Provides oncology-focused medical oversight, real-time patient safety review, and protocol deviation management.

    Assays & in vitro testing

  • eTMF management

    Manages electronic trial master files and trial documentation for regulatory readiness.

    Assays & in vitro testing

  • Quality assurance

    Conducts audits and quality management activities to support trial compliance and integrity.

    Assays & in vitro testing

  • Translational regulatory services

    Provides regulatory planning, consulting, and translational support for oncology development programs.

  • Regulatory & medical writing

    Prepares regulatory and medical writing deliverables for oncology programs and submissions.

  • Gap analysis & roadmap development

    Assesses development packages, identifies missing elements, and builds a roadmap toward FDA submission and clinic entry.

  • Protocol design

    Designs protocols for oncology development programs, including translational and clinical work.

  • Program budget & timeline

    Builds program budgets and timelines for development planning.

  • Preclinical model systems

    Offers syngeneic, orthotopic, PDX, humanized mouse, diet-induced obesity tumor, adoptive cell therapy, and CDX models.

  • Bioanalytical services

    Provides bioanalytical support for preclinical oncology studies.

    Assays & in vitro testing

  • Preclinical flow cytometry

    Offers flow cytometry analysis for preclinical studies, including immunophenotyping and biomarker evaluation.

    Assays & in vitro testing

  • Metabolomics and proteomics analysis

    Performs metabolomic and proteomic analysis for preclinical and early clinical oncology studies.

    Assays & in vitro testing

  • DMPK/ADME services

    Provides drug metabolism, pharmacokinetics, and absorption, distribution, metabolism, and excretion support.

    ADME, DMPK & toxicology

  • In vivo and in vitro characterization

    Characterizes investigational compounds in vivo and in vitro for oncology programs.

    Assays & in vitro testing

  • In vivo optical imaging

    Uses optical imaging to monitor tumor growth kinetics and disease progression in preclinical models.

    Assays & in vitro testing

  • Therapeutic evaluation

    Evaluates therapeutic response in preclinical oncology studies.

    Assays & in vitro testing

  • PK/ADME

    Provides pharmacokinetic and ADME support, including PK, PD, and biomarker analyses.

    ADME, DMPK & toxicology

  • Clinical trial services for radiopharmaceuticals

    Supports radiopharmaceutical trial design, regulatory strategy, site feasibility, and clinical execution.

    Assays & in vitro testing

  • Clinical trial services for hematologic malignancies

    Supports hematology-oncology trials for leukemia, lymphoma, multiple myeloma, AML, MDS, and myelofibrosis.

    Assays & in vitro testing

  • Clinical trial services for antibody-drug conjugates

    Supports ADC clinical trials with trial design, bioanalytics, and safety monitoring.

    Assays & in vitro testing

  • Clinical trial services for small molecules

    Supports small molecule oncology development from first-in-human through regulatory approval.

    Assays & in vitro testing

What to send
Biological samples: plasma, serum, tissues · Tissues including tumor, brain, heart, kidneys, lungs, muscles · Whole blood, bone marrow, spleen, and tumor · PBMC services

Capabilities

Assays and studies
Flow cytometry · ADCs · Antibodies · ADME · In vivo · Cell therapy · Small molecules · Bioanalysis · Rodent models · Biostatistics · Pharmacovigilance · Medical monitoring
13 morePK/PD analysis · Metabolomics · Proteomics · DMPK · Optical imaging · LC-MS/MS · UV-VIS · PAMPA · Caco-2 · CYP phenotyping · Clinical flow cytometry · Preclinical flow cytometry · PK/ADME
Scale and capacity
Over 400 models of cancer · AAALAC-accredited vivarium
Therapeutic areas
Radiopharmaceuticals · Hematologic malignancies · Antibody-drug conjugates · Small molecules · Cancer vaccine development · Oncology · Autoimmune disease · Allergy · Inflammatory disorders

Instruments and platforms

  • Waters Xevo TQ-S
  • Acquity I-class UPLC system
  • Spectral Instruments Imaging AMI HTX
  • Aura imaging software 4.0
  • Phoenix WinNonlin software
  • PET
  • SPECT

Modalities and species

Modalities
Small molecule · Antibody · ADC · Cell therapy · Vaccine
Species and models
Syngeneic tumor models · Orthotopic tumor models · Patient derived xenograft (PDX) models · Humanized mouse models · Diet-induced obesity tumor model · Adoptive cell therapy models · Cell line derived xenografts (CDX) · Mouse · PBMC · Whole blood · Bone marrow · Spleen
6 moreTumors · Lymph nodes · Patient-derived xenograft (PDX) models · Cell line derived xenografts (CDX) models · PET · SPECT

Industries served

  • Biotech
  • Pharmaceutical
  • Oncology

Company

Type
CRO
Founded
2003
Quality
AAALAC-accredited (vivarium) · GCP (clinical trial activities) · GCP (Good Clinical Practice)

Locations

Address
13208 E. Shea Blvd, Suite 100 Scottsdale, AZ 85259
Sites
Scottsdale, United States
Serves
global

Contacts

Similar labs

Work here? Claim this listing